Carvedilol improves ethanol-induced liver injury via modifying the interaction between oxidative stress and sympathetic hyperactivity in rats

Hepatology Research

Volumn 44, Issue 5, 2014, Pages 560-570

  Hakucho, Ayako ^a   Liu, Jinyao ^a   Liu, Xu ^a   Fujimiya, Tatsuya ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alcoholic liver disease; Ethanol; Oxidative stress; Sympathetic activity

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ALCOHOL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CARVEDILOL; COPPER ZINC SUPEROXIDE DISMUTASE; INSULIN RECEPTOR SUBSTRATE 1; NORADRENALIN; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; FLUORESCENCE IMMUNOHISTOCHEMISTRY; GENE EXPRESSION; HISTOPATHOLOGY; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER CELL; LIVER INJURY; LIVER WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; SYMPATHETIC HYPERACTIVITY; SYMPATHETIC TONE; UPREGULATION; WESTERN BLOTTING;

EID: 84899079817     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12143     Document Type: Article

References (45)

1. Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009; 83: 519-548.
2. Zhu R, Wang Y, Zhang L, Guo Q. Oxidative stress and liver disease. Hepatol Res 2012; 42: 741-749.
3. Comporti M, Signorini C, Leoncini S etal. Ethanol-induced oxidative stress: basic knowledge. Genes Nutr 2010; 5: 101-109.
4. Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health 2003; 27: 277-284.
5. Bravo IR, Acevedo CG, Gallardo V. Acute effects of ethanol on liver blood circulation in the anesthetized dog. Alcohol Clin Exp Res 1980; 4: 248-253.
6. Liu J, Fujimiya T. Abrupt termination of an ethanol regimen provokes ventricular arrhythmia and enhances susceptibility to the arrhythmogenic effects of epinephrine in Rats. Alcohol Clin Exp Res 2010; 34: S45-53.
7. Patterson-Buckendahl P, Kubovcakova L, Krizanova O, Pohorecky LA, Kvetnansky R. Ethanol consumption increases rat adrenomedullary gene expression. Alcohol 2005; 37: 157-166.
8. Montfort CV, Beier JI, Guo L, Kaiser JP, Arteel GE. Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1227-1234.
9. 2A-adrenoceptors and downregulation of MKP-1 mediate hepatic injury in chronic alcohol exposure. Biochem Biophys Res Commun 2011; 409: 406-411.
10. Liu J, Takase I, Hakucho A, Okamura N, Fujimiya T. Carvedilol attenuates the progression of alcohol fatty liver disease in rats. Alcohol Clin Exp Res 2012; 36: 1587-1599.
11. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J 1996; 17: B24-29.
12. Nakamura K, Kusano K, Nakamura Y etal. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 2002; 105: 2867-2871.
13. Li YC, Ge LS, Yang PL etal. Carvedilol treatment ameliorates acute coxackievirus B3-induced myocarditis associated with oxidative stress reduction. Eur J Pharmacol 2010; 640: 112-116.
14. Arozal W, Watanabe K, Veeraveedu PT etal. Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats. Toxicology 2010; 274: 18-26.
15. Hamdy N, El-Demerdash E. New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage. Toxicol Appl Pharmacol 2012; 261: 292-299.
16. Bakris GL, Fonseca V, Katholi RE etal. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004; 292: 2227-2236.
17. Liang Y, Cincotta AH. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice. Int J Obes 2001; 25: 698-704.
18. Chang L, Chiang SH, Saltiel AR. Insulin signaling and the regulation of glucose transport. Mol Med 2004; 10: 65-71.
19. de la Monte SM, Yeon JE, Tong M etal. Insulin resistance in experimental alcohol-induced liver disease. J Gastroenterol Hepatol 2007; 23: e477-486.
20. Lieber CS, DeCarli LM. Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol 1989; 24: 197-211.
21. Shirafuji S, Liu J, Okamura N, Hamada K, Fujimiya T. QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal. Alcohol Clin Exp Res 2010; 34: 223-230.
22. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′-deoxyguanosine [8-OHdG]: a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C 2009; 27: 120-139.
23. Yao XH, Chen L, Nyomba BL. Adult rats prenatally exposed to ethanol have increased gluconeogenesis and impaired insulin response of hepatic gluconeogenic genes. J Appl Physiol 2006; 100: 642-648.
24. Carreras MC, Poderoso JJ. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am J Physiol Cell Physiol 2007; 292: C1569-1580.
25. McCord J. Iron, free radicals and oxidative injury. Semin Hematol 1998; 35: 5-12.
26. Nakazawa J, Genka C, Fujishima M. Pathological aspects of active oxygens/free radicals. Jpn J Physiol 1996; 46: 15-32.
27. Kim YD, Eom SY, Ogawa M etal. Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice. J Occup Health 2007; 49: 363-369.
28. Chen CH, Pan CH, Chen CC, Huang MC. Increased oxidative DNA damage in patients with alcohol dependence and its correlation with alcohol withdrawal severity. Alcohol Clin Exp Res 2011; 35: 338-344.
29. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74: 139-162.
30. Curry-McCoy TV, Osna NA, Nanji AA, Donohue TM. Jr. Chronic ethanol consumption results in atypical liver injury in copper/zinc superoxide dismutase deficient mice. Alcohol Clin Exp Res 2010; 34: 251-261.
31. ·-), superoxide dismutases, and related matters. J Biol Chem 1997; 272: 18515-18517.
32. Koch OR, Pani G, Borrello S etal. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med 2004; 25: 191-198.
33. Boschloo L, Vogelzangs N, Licht CMM etal. Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Drug Alcohol Depend 2011; 116: 170-176.
34. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 2004; 287: 695-703.
35. Kishi T, Sunagawa K. Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats. Circ J 2012; 76: 1934-1941.
36. Crespo ME, Bicho MP. Membrane-mediated effects of catecholamines on the DNA of human leukocytes: the role of reactive oxygen species. Biol Signals 1995; 4: 78-85.
37. Macarthur H, Westfall TC, Wilken GH. Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2008; 294: H183-189.
38. Ramirez T, Longato L, Dostalek M etal. Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis. Alcohol Alcohol 2013; 48: 39-52.
39. Haenni A, Lithell H. Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension. Metabolism 1994; 43: 455-461.
40. Giovannone B, Scaldaferri ML, Federici M etal. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev 2000; 16: 434-441.
41. Zhong W, Zhao Y, Tang Y etal. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol 2012; 180: 998-1007.
42. Vera M, Nieto N. Hepatic stellate cells and alcoholic liver disease. Rev Esp Enferm Dig 2006; 98: 674-684.
43. MsCuskey RS. Anatomy of efferent hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol 2004; 280A: 821-826.
44. Oben JA, Roskams T, Yang S etal. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004; 53: 438-445.
45. Sancho-Bru P, Bataller R, Colmenero J etal. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2006; 291: G877-884.